Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: The second part of a two-part Canadian Corner article on Segregated Fund Guarantees. Part I ran in the June 1998 issue of Product Development News.

Description: This article was written to increase the knowledge and insights of both the direct writer and reinsurer in optimizing the reinsurance negotiation process. It should help the reinsurer offer a more competitive quote and hence win a share in a reinsurance pool while simultaneously helping the direct writer obtain lower reinsurance costs helping their product pricing and bottom line.

Description: In 2014, the SOA Product Development and Reinsurance Sections, along with the Committee for Life Insurance research engaged Reinsurance Group of America to undertake a research project on term conversion experience.

Description: The purpose of this article is to discuss some of the challenges insurance companies face when participating in the immediate annuity market for retirement income planning and to suggest ways that reinsurers could be of service to the direct writers of immediate annuities.

Description: Overview of the diverse Asia markets and four key themes:Rapid pace of product development, innovative underwriting solutions, Wellness, the rise of insurtech.

Description: Our goal in this article is to dive deeper into the role longevity swaps could play in the US PRT market by drawing comparisons to the UK and highlighting recent commercial developments that can jump start the US market’s need for longevity reinsurance.

Description: Key considerations when modeling reinsurance to calculate reserves under PBR as well as a case study examining the impact of reinsurance structures on reserves.

Description: This article contains a summary of some of the presentations given at the October 2012 SOA Annual Meeting. This article does not cover all sessions that are related to product development, but shares observations that have been made by various members of the SOA Product Development Section Council.

Description: An update on HMO market trends and reinsurance products, and services supporting them.